Disclosure Quest - Search SEC Filings

More options

Type of Offering

Amount To Be Raised

to

Filing Date

to

Type of Security

Industry

CIK Number

Principal Place Of Business

Found 5 results

Name	Type of Offering	Accepted Date
Invirsa, Inc. See All Filings	D/A	2025-08-08 15:50:20 UTC
Amount To Be Raised $2,860,000 Associated Brokers / Dealers N/A CIK Number 0001836108 Filed Document 0001836108-25-000003 Exclusions or Exemptions 506b Accepted Date 2025-08-08 15:50:20 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business OHIO Revenue or Assets Decline to Disclose Type of Security Equity
Invirsa, Inc. See All Filings	D	2025-08-05 19:27:47 UTC
Amount To Be Raised $2,832,000 Associated Brokers / Dealers N/A CIK Number 0001836108 Filed Document 0001836108-25-000002 Exclusions or Exemptions 506b Accepted Date 2025-08-05 19:27:47 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business OHIO Revenue or Assets Decline to Disclose Type of Security Equity
Invirsa, Inc. See All Filings	D	2023-11-28 18:44:20 UTC
Amount To Be Raised $999,998 Associated Brokers / Dealers N/A CIK Number 0001836108 Filed Document 0001836108-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-11-28 18:44:20 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business OHIO Revenue or Assets Decline to Disclose Type of Security Equity
Invirsa, Inc. See All Filings	D	2022-12-29 12:38:44 UTC
Amount To Be Raised $7,700,000 Associated Brokers / Dealers N/A CIK Number 0001836108 Filed Document 0001836108-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-12-29 12:38:44 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business OHIO Revenue or Assets Decline to Disclose Type of Security Equity
Invirsa, Inc. See All Filings	D	2020-12-11 15:39:29 UTC
Amount To Be Raised $40,245 Associated Brokers / Dealers N/A CIK Number 0001836108 Filed Document 0001836108-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-12-11 15:39:29 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business OHIO Revenue or Assets Decline to Disclose Type of Security Equity